Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

CFTR modulators

How sweat chloride levels relate to health improvements with CFTR modulators

  • Read more about How sweat chloride levels relate to health improvements with CFTR modulators

Tracking the journey of elexacaftor-tezacaftor-ivacaftor in the bodies of children with cystic fibrosis

  • Read more about Tracking the journey of elexacaftor-tezacaftor-ivacaftor in the bodies of children with cystic fibrosis

CFTR modulators and pregnancy outcomes: early findings from a nationwide cohort study

  • Read more about CFTR modulators and pregnancy outcomes: early findings from a nationwide cohort study

Kaftrio® quickly modifies the composition of breath in children with CF.

  • Read more about Kaftrio® quickly modifies the composition of breath in children with CF.

A review of research about Trikafta and mental health: a report from Cystic Fibrosis Foundation’s Prioritizing Research in Mental Health Working Group

  • Read more about A review of research about Trikafta and mental health: a report from Cystic Fibrosis Foundation’s Prioritizing Research in Mental Health Working Group

Elexacaftor/tezacaftor/ivacaftor can be effective for people with cystic fibrosis with the 3849 gene variant

  • Read more about Elexacaftor/tezacaftor/ivacaftor can be effective for people with cystic fibrosis with the 3849 gene variant

What is the best approach to bring drugs to all people with CF?

  • Read more about What is the best approach to bring drugs to all people with CF?

Differences between the United States and the European Union in the time of approval of CFTR modulators for the treatment of cystic fibrosis

  • Read more about Differences between the United States and the European Union in the time of approval of CFTR modulators for the treatment of cystic fibrosis

Correlation between trough concentration and exposure during the day for elexacaftor, tezacaftor and ivacaftor

  • Read more about Correlation between trough concentration and exposure during the day for elexacaftor, tezacaftor and ivacaftor

CFTR modulators in people with CF and the I1234V mutation

  • Read more about CFTR modulators in people with CF and the I1234V mutation
  • 1
  • 2
  • 3
  • 4
  • 5
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)